Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 32
Filter
1.
Rev. chil. enferm. respir ; 38(2): 96-105, jun. 2022. tab, ilus
Article in Spanish | LILACS | ID: biblio-1407775

ABSTRACT

Resumen En la práctica clínica, la radiografía de tórax permite confirmar el diagnóstico y la extensión de la neumonía adquirida en la comunidad (NAC). Objetivos: Examinar las características radiográficas de la NAC según el agente causal y el grado de concordancia interobservador (CI) en la descripción de los hallazgos radiográficos. Métodos: Se evaluaron las radiografías de tórax de 300 pacientes adultos inmunocompetentes hospitalizados por NAC, tres residentes de radiología consignaron el patrón de los infiltrados pulmonares, su localización anatómica y extensión, la presencia de derrame pleural y otros hallazgos radiográficos. Se realizaron cultivos de esputo, hemocultivos, pruebas serológicas y técnicas de biología molecular de hisopado nasofaríngeo para identificar los principales patógenos respiratorios. Resultados: Las manifestaciones clínicas y los hallazgos de la radiografía de tórax fueron similares en las neumonías causadas por diferentes patógenos respiratorios: bacterias clásicas, virus respiratorios y microorganismos atípicos. En las neumonías bacterianas predominó el patrón de relleno alveolar de distribución lobar, en las neumonías vírales y atípicas predominó el patrón intersticial o mixto alvéolo-intersticial con opacidades en vidrio esmerilado. La CI fue satisfactoria (kappa > 0,6) para determinar el patrón principal de los infiltrados pulmonares, su localización anatómica y la presencia de derrame pleural, su localización y extensión. La CI fue moderada (kappa 0,4-0,6) para definir la extensión de la neumonía y detectar signos radiológicos asociados a congestión pulmonar. Conclusión: Los hallazgos de la radiografía de tórax no permitieron identificar con precisión el agente causal de la neumonía, siendo útil en la caracterización de los infiltrados pulmonares y para detectar complicaciones como el derrame paraneumónico.


In a clinical setting the chest radiograph is the reference standard in establishing the diagnosis of community-acquired pneumonia (CAP). Objectives: This study aimed to assess interobserver reliability (IR) of radiographic findings and the relationship to different respiratory pathogens in CAP. Methods: Chest radiographs of 300 immunocompetent adult patients hospitalized with pneumonia, obtained from a database, were reviewed by three residents of radiology without specific clinical information. Main pattern of pulmonary infiltrates, topographic localization, extent of pneumonia, presence of pleural fluid, thickened bronchial walls, lymphadenopathy and air bronchogram were scored. Sputum and blood cultures, serological tests and nasopharyngeal swab for respiratory virus detection by molecular diagnostic techniques were performed to identify the causative pathogen. Results: Clinical manifestations and chest X-ray findings were similar in pneumonias caused by different respiratory pathogens: classic bacteria, respiratory viruses and atypical microorganisms. The alveolar pattern of lobar distribution predominated in bacterial pneumonia; meanwhile, interstitial or mixed alveolar-interstitial pattern with ground glass opacities predominated in viral and atypical pneumonias. IR was fair to good (kappa > 0.6) for determining the main pattern of infiltrates, anatomical location and the presence of pleural effusion, their anatomical location and extension. IR was moderate (kappa 0.4-0.6) for determining the extent of pneumonia and signs of congestive heart failure. Conclusion: Simple features such as main pattern description, anatomical location, identifying the involved lobes and pleural fluid recognition showed fair to excellent interobserver reliability. Chest radiographs was of limited value in predicting the causative pathogen but were of beneficial use to characterize pulmonary infiltrates and to detect complications such as parapneumonic effusion.


Subject(s)
Humans , Male , Female , Adolescent , Adult , Middle Aged , Aged , Aged, 80 and over , Young Adult , Community-Acquired Infections/etiology , Community-Acquired Infections/diagnostic imaging , Bacteria/isolation & purification , Viruses/isolation & purification , Radiography, Thoracic , Observer Variation , Prospective Studies , Reproducibility of Results , Community-Acquired Infections/microbiology , Community-Acquired Infections/virology , Immunocompetence
2.
Rev. cuba. med ; 60(1): e1397, tab, graf
Article in Spanish | LILACS, CUMED | ID: biblio-1156559

ABSTRACT

Introducción: Un instrumento ha sido utilizado para la estratificación de pacientes con neumonía adquirida en la comunidad en el Departamento de urgencias desde 2006. Objetivo: Evaluar el proceso de estratificación de pacientes con neumonía adquirida en la comunidad de pacientes hospitalizados. Métodos: Estudio descriptivo que incluyó 1 809 pacientes hospitalizados en el Departamento de urgencias entre los años 2009 y 2019. Para la evaluación del proceso se realizó una estratificación de control que permitió determinar la frecuencia y calidad de la estratificación inicial, así como la coincidencia entre esta y la estratificación real. En el análisis estadístico se utilizó la razón de productos cruzados (Odds Ratio) y el estadígrafo X2 para diferencias de proporciones; se aceptó un nivel de significación de 95 por ciento. Resultados: El índice de estratificación de la serie fue de 86 por ciento, y el índice de estratificación adecuada fue de 80 por ciento. Predominaron los pacientes con neumonía moderada y altas probabilidades de evolución desfavorable. La menor estratificación se comprobó en los pacientes con neumonía grave y altas probabilidades de recuperación (p<,05). Hubo diferencias en la calidad de la estratificación entre las agrupaciones de los estratos IA-IB-IIA y IIB-IIIA-IIIB (p<,05). Estos tres últimos estratos presentaron las cifras más altas del valor predictivo positivo de la estratificación inicial (p<,05). Conclusiones: El proceso de estratificación de pacientes con neumonía adquirida en la comunidad hospitalizados se caracterizó por una elevada frecuencia de estratificación y una adecuada calidad. No obstante, fueron identificados grupos de pacientes y situaciones específicas que se consideran áreas de superación de importancia para el mejoramiento de la calidad asistencia(AU)


Introduction: An instrument has been used for stratifying patients with community-acquired pneumonia in the emergency department since 2006. Objective: To evaluate the stratifying process of patients with community-acquired pneumonia in hospitalized patients. Methods: A descriptive study that included 1 809 patients hospitalized in the emergency department from 2009 to 2019 was carried out. A control stratification evaluated the process, which allowed determining the frequency and quality of the initial stratification, as well as the coincidence between this and the actual stratification. In the statistical analysis, the ratio of crossed products (Odds Ratio) and X2 statistic were used for differences in proportions; a significance level of 95 percent was accepted. Results: The stratification index of the series was 86 percent, and the adequate stratification index was 80 percent. Patients with moderate pneumonia and high probabilities of unfavorable evolution predominated. The lowest stratification was found in patients with severe pneumonia and high probability of recovery (p <.05). There were differences in the quality of stratification between the groupings of strata IA-IB-IIA and IIB-IIIA-IIIB (p <.05); these last three strata sowed the highest figures of the positive predictive value of the initial stratification (p <.05). Conclusions: The stratification process of hospitalized community-acquired pneumonia patients was characterized by high stratification frequency and adequate quality. However, this study identified groups of patients and specific situations that were considered as areas of improvement, important for improving the quality of care(AU)


Subject(s)
Humans , Pneumonia/epidemiology , Emergency Medical Services , Epidemiology, Descriptive , Community-Acquired Infections/etiology
4.
Rev. pediatr. electrón ; 14(1): 35-37, 2017.
Article in Spanish | LILACS | ID: biblio-969292

ABSTRACT

La neumonía adquirida en la comunidad ocurre en pacientes previamente sanos y su principal etiología es viral. Dentro de las etiologías bacterianas la principal en el recién nacido es el S. agalactiae y en los mayores es S. pneumoniae. Es la principal causa de muerte en niños menores de 5 años de edad en el mundo. Su diagnóstico se basa en la anamnesis y los hallazgos clínicos clásicos, pudiendo complementarse el estudio con radiografía de tórax e identificación viral con métodos rápidos. Su manejo depende de la etiología, y se indica antibioticoterapia (de elección amoxicilina v.o. o ampicilina e.v.) solo frente a la sospecha fundada de etiología bacteriana. Además se debe dar soporte según los requerimientos del paciente, incluyendo la hospitalización si cumple los criterios para ésta. La necesidad de cirugía está restringida principalmente para el manejo de empiemas.


Community acquired pneumonia occurs in previously healthy children and its ethnology is viral. Bacterial ethnology are S. agalactiaein neonates and S. pneumoniaein the olders. Is the main cause of death in children under 5 years of age. Diagnosis is made base on clinical features and chest X ray. Treatment depends on the etiology and antibiotics, preference oral amoxicilin or iv ampiciline, are indicated when a bacterial ethnology is suspected.


Subject(s)
Humans , Child , Pneumonia/diagnosis , Pneumonia/therapy , Community-Acquired Infections/diagnosis , Community-Acquired Infections/therapy , Pneumonia/complications , Pneumonia/etiology , Community-Acquired Infections/complications , Community-Acquired Infections/etiology
5.
Med. infant ; 21(2): 90-96, Junio 2014. tab, ilus
Article in Spanish | LILACS | ID: biblio-911462

ABSTRACT

Introducción: La neumonía adquirida en la comunidad (NAC) representa una de las principales causas de morbi-mortalidad en Pediatría. Su etiología es variable. Material y métodos: Cohorte prospectiva.1/04/2012 al 31/03/2013. Criterios de inclusión: edad entre 1 mes y 15 años, internados en el Hospital de Pediatría Juan P. Garrahan, Rx de tórax y clínica compatible con NAC. Análisis estadístico: Epi info 3.2.2. Resultados: n: 305, 55,4% (n: 169) varones. Edad (mediana) 13,3 meses (rango: 1-180). Enfermedad de base 47,9% (n: 146). Se identificó agente etiológico de NAC en 50,8% (n: 155); de ellos 79,3% (n: 119) fueron virus y 31,3% (n: 47) bacterias. En 11 pacientes (7,1%), ya incluidos en las cifras anteriores, se detectó una coinfección bacteria-virus. Tuvieron bacteriemia 7,9% (n: 24). Los virus identificados más frecuentemente fueron VSR (60,5%; n: 72), ADV (18,5%; n: 22) y Parainfluenza (8,4%; n: 10). Streptococcus pneumoniae representó el 38,2% (n: 18) y Staphylococcus aureus 36.2% (n: 17) de los aislamientos bacterianos (n: 47). Requirieron UCI el 17% (n: 52) de los niños y 1,6% (n: 5) fallecieron por una causa relacionada con la infección. La duración de la internación fue 11,02 días (r: 2-104). Predominaron los menores de 2 años (68,5%; n: 209). Los mayores de 2 años tuvieron más derrame pleural (13,4% vs 39,6%; OR 0,3; IC 95% 0,2 a 0,5; p 0,001), condensación lobar (37,3% vs 49%; OR 0,76; IC 95% 0,58 a 0,99) y pulmonar (5,3% vs 12,5%; OR 0,42; IC 95% 0,14 a 0,92) que los menores. Los virus fueron más frecuentes en los menores de 2 años que en los mayores. (51,1% vs 13,5%; OR 6,5; IC 95% 3,43 a 12,48). Conclusiones: La identificación del agente etiológico es alta si se emplean métodos convencionales (cultivos) y de biología molecular. Las infecciones virales predominaron en los menores de 2 años (AU)


Introduction: Community-acquired pneumonia (CAP) is one of the main causes of morbidity and mortality in pediatrics. Its etiology is variable. Material and methods: Prospective cohort study.1/04/2012 to 31/03/2013. Inclusion criteria: Age between 1 month and 15 years, admission to the Pediatric Hospital Juan P. Garrahan, chest x-rays and clinical features compatible with CAP. Statistical analysis: Epi info 3.2.2. Results: n: 305, 55.4% (n: 169) boys. Age (median) 13.3 months (range: 1-180). Underlying disease 47.9% (n: 146). The etiological agent of CAP was identified in 50.8% (n: 155); of which 79.3% (n: 119) were viruses and 31.3% (n: 47) bacteria. In 11 patients (7.1%), included in the previous numbers, a bacteria-virus coinfection was found. Bacteremia was observed in 7.9% (n: 24). The most frequently identified viruses were SRV (60.5%; n: 72), ADV (18.5%; n: 22), and parainfluenza (8,4%; n: 10). Streptococcus pneumoniae accounted for 38.2% (n: 18) and Staphylococcus aureus for 36.2% (n: 17) of the bacterial isolates (n: 47). Of all children, 17% (n: 52) required ICU admission and 1.6% (n: 5) died because of infection-related causes. Median hospital stay was 11,02 days (r: 2-104). There was a predominance of children under 2 years of age (68.5%; n: 209). Children older than 2 years more frequently had pleural effusion (13.4% vs 39.6%; OR 0.3; 95% CI 0.2 to 0.5; p 0001), and lobular (37.3% vs 49%; OR 0.76; 95% CI 0.58 to 0.99) and pulmonary condensation (5.3% vs 12.5%; OR 0.42; 95% CI 0.14 to 0.92) than younger patients. Viruses were more frequently found in children under 2 years of age than in the older patients (51.1% vs 13.5%; OR 6.5; 95% CI 3.43 to 12.48). Conclusions: The possibility to identify the etiological agent is high when using conventional methods (cultures) and molecular biology. Viral infections predominated in children younger than 2 years of age (AU)


Subject(s)
Humans , Infant , Child, Preschool , Child , Adolescent , Pneumonia/diagnosis , Pneumonia/etiology , Pneumonia/mortality , Pneumonia/epidemiology , Community-Acquired Infections/etiology , Bacterial Infections/etiology , Virus Diseases/etiology , Prospective Studies , Cohort Studies
6.
Neumol. pediátr ; 8(2): 53-65, 2013. ilus, tab
Article in Spanish | LILACS | ID: lil-701690

ABSTRACT

Respiratory infections of lower respiratory tract remain a major cause of mortality in young children worldwide, particularly in developing countries. The Community Acquired Pneumonia (CAP), the infectious etiology pneumonia acquired by a previously healthy individual outside a hospital. In 2012, WHO stated that S. pneumoniae and H. influenzae type b (Hib) are the first and second most common cause of bacterial pneumonia in children, respectively, whereas Respiratory Syncytial Virus is the most frequent cause of viral pneumonia. The assessment and treatment of a child with a respiratory infection of lower airways becomes a challenge as not only the clinical manifestations of infection by viruses, bacteria or atypical bacteria may overlap, but also coinfections occur frequently. The etiological agents of pneumonia in children can be divided into three groups: common bacteria(S. pneumoniae, H. influenzae, S. aureus, M. catarrhalis, S. pyogenes, B. pertussis, M. tuberculosis, among others),respiratory viruses (RSV, Influenza A and B, Parainfluenza 1, 2 and 3, Adenovirus, Rhinovirus, Coronavirus, Metapneumovirus, Bocavirus, Enterovirus, Varicella Zoster, among others) and atypical pathogens (M. pneumoniae, C. pneumoniae, C. trachomatis, L. pneumophila, C. burnetii, among others). The etiological diagnosis of CAP in pediatric patients is supported by laboratory tests that generate direct or indirect evidence of the causal germ. The search for the causing agent becomes a challenge, primarily due to the limitation in obtaining appropriate samples and the difficulty to identify the etiological agent and differentiate between colonization and infection. With the available methods, a specific germ is expected to be detected from 16 to 85 percent of the cases, making it difficult to determine the true incidence of these infections. In addition, the variety of diagnostic techniques used in clinical trials and interpretation of the results in the absence...


Las infecciones respiratorias de vías aéreas inferiores siguen siendo una de las principales causas de mortalidad en niños pequeños alrededor del mundo, particularmente en países en desarrollo. La Neumonía Adquirida en la Comunidad (NAC), es la neumonía de etiología infecciosa que adquiere un individuo previamente sano, fuera de un hospital. En el 2012, la OMS, establece que S. pneumoniae y H. influenzae tipo b (Hib) son la primera y segunda causa más común de etiología bacteriana en niños, respectivamente; mientras que el Virus Sincitial Respiratorio es la causa más frecuente de neumonía viral. La evaluación y el manejo de un niño con una infección respiratoria de vías aéreas inferiores, se convierte un reto ya que no sólo las manifestaciones clínicas de las infecciones por virus, bacterias o bacterias atípicas pueden solaparse, sino que también ocurren frecuentemente coinfecciones. Los agentes etiológicos de las neumonías en niños se pueden dividir en 3 grupos: bacterias comunes (S. pneumoniae, H. influenza, S. aureus, M. catarrhalis, S. pyogenes, B. pertussis, M. tuberculosis, entre otros), virus respiratorios (VSR, Influenza A y B, Parainfluenza 1, 2 y 3, Adenovirus, Rhinovirus, Coronavirus, Metapneumovirus, Bocavirus,Enterovirus, Varicela, entre otros) y gérmenes atípicos (M. pneumoniae, C. pneumoniae, C. trachomatis, L. pneumophila, Coxiella burnetii, entre otros). El diagnóstico etiológico de NAC en el paciente pediátrico se apoya en pruebas de laboratorio que generan una evidencia directa o indirecta del germen causal. La búsqueda del agente causal se convierte en un reto debido principalmente a la limitación para obtener muestras adecuadas y a la dificultad de identificar el agente etiológico y diferenciar entre colonización e infección. Con los métodos disponibles se estima que se puede detectar un germen específico entre el 16 al 85 por ciento de los casos; lo cual dificulta la determinación de la incidencia real de estas infecciones...


Subject(s)
Humans , Child , Community-Acquired Infections/etiology , Pneumonia, Bacterial/etiology , Pneumonia, Viral/etiology , Bacteria/pathogenicity , Pneumonia, Bacterial/diagnosis , Pneumonia, Bacterial/epidemiology , Pneumonia, Viral/diagnosis , Pneumonia, Viral/epidemiology , Risk Factors , Seasons , Viruses/pathogenicity
7.
Rev. am. med. respir ; 12(4): 131-139, dic. 2012. tab
Article in Spanish | LILACS | ID: lil-667892

ABSTRACT

Objetivos: Conocer la frecuencia de Staphylococcus aureus meticilino resistente adquirido en la comunidad (SAMR-AC) en neumonía adquirida en la comunidad (NAC); examinar sus características clínicas - evolutivas y analizar factores de riesgo. Pacientes, material y métodos: Estudio retrospectivo, descriptivo, observacional, realizado en una unidad de cuidados intensivos respiratorios entre 2006 y 2012. Resultados: Se evaluaron 180 pacientes con NAC con diagnóstico etiológico. Etiologías más frecuentes: Streptococcus pneumoniae (50.5%), Haemophillus influenzae (18.3%) ySAMR-AC (12.2%, 22 casos). La neumonía por SAMR-AC se presentó en individuos jóvenes, mayoritariamente hombres. En el 81.8% de los casos el foco primario fue infección de piel y estructuras relacionadas (IPER), 95.4% presentó criterios clínicos de sepsis, 72.7% tuvo compromiso radiológico bilateral y 45.5% desarrolló derrame pleural. El 40.9% requirió ventilación mecánica y el 45.4% utilizó drogas vasoactivas. El 81.8% de los pacientes no alcanzó criterios de estabilidad clínica al cabo de la primer semana y la mortalidad fue del 36.3%, significativamente superior al resto de los microorganismos (8.8%, p<0,001). Los factores clínicos asociados con mayor riesgo de SAMR-AC fueron la presencia de IPER concomitante, compromiso radiológico bilateral, presencia de criterios clínicos de sepsis, edad inferior a 30 años y requerimiento de drogas vasoactivas. Los factores que se asociaron con mortalidad en NAC fueron la etiología por SAMR-AC y el compromiso radiológico bilateral. Conclusiones: La neumonía por SAMR-AC es una patología emergente, asociada a elevada morbimortalidad. Debe ser considerada en pacientes jóvenes, con presencia concomitante de IPER, compromiso radiológico bilateral, criterios clínicos de sepsis o necesidad de drogas vasoactivas.


Objectives: To know the incidence of Community Acquired Pneumonia (CAP) caused by Methicillin Resistant Sthaphylococcus aureus (MRSA), to examine their clinical and developmental characteristics and to analyze risk factors. Materials and Methods: Retrospective, descriptive and observational study carried out at a Respiratory Intensive Care Unit, between 2006 and 2012. Results: 180 patients with etiologic diagnosis of CAP were evaluated. The most common causes were Streptococcus pneumoniae (50.5%), Haemophillus influenzae (18.3%) and MRSA (12.2%, 22 cases). Community Acquired MRSA (CA-MRSA) pneumonia was present in young people, especially in male. In 81.8% of the cases, skin and related structure infections (SRSI) were the primary focus, 95.4% presented clinical criteria of sepsis, 72.7% had bilateral radiology involvement and 45.5% developed pleural effusion. 40.9% needed mechanical ventilation and 45.4% used vasoactive drugs. Clinical stability at the first week was not reached in 81.8% and mortality rate was 36.6%, significantly higher than for pneumonia caused by other microorganisms (8.8% p<0,001). Clinical factors related with high risk of CA-MRSA pneumonia were the concomitant presence of SRSI, bilateral radiology involvement, clinical criteria of sepsis, age <30 years old and need for vasoactive drugs. Factors related to CAP mortality were CA-MRSA aetiology and bilateral radiology involvement. Conclusions: CA-MRSA pneumonia is an emergent disease with high morbidity and mortality. It must be considered in young patients, with SRSI, bilateral radiology involvement, clinical criteria of sepsis or intake of vasoactive drugs.


Subject(s)
Humans , Adult , Community-Acquired Infections/diagnosis , Community-Acquired Infections/etiology , Staphylococcal Infections/diagnosis , Staphylococcal Infections/microbiology , Staphylococcal Infections/therapy , Pneumonia, Staphylococcal/microbiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Anti-Bacterial Agents/administration & dosage , Cohort Studies , Risk Factors
10.
Journal of Korean Medical Science ; : 313-316, 2012.
Article in English | WPRIM | ID: wpr-73174

ABSTRACT

Panton-Valentine leukocidin (PVL)-positive USA300 clone has been the most successful community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) clone spreading in North America. In contrast, PVL-negative ST72-CA-MRSA has been predominant in Korea, and there has been no report of infections by the USA300 strain except only one case report of perianal infection. Here, we describe the first case of pneumonia caused by the USA300 strain following pandemic influenza A (H1N1) in Korea. A 50-year-old man was admitted with fever and cough and chest radiograph showed pneumonic consolidation at the right lower lung zone. He received a ventilator support because of respiratory failure. PCR for pandemic influenza A (H1N1) in nasopharyngeal swab was positive, and culture of sputum and endotracheal aspirate grew MRSA. Typing of the isolate revealed that it was PVL-positive, ST 8-MRSA-SCCmec type IV. The analysis of the PFGE patterns showed that this isolate was the same pulsotype as the USA300 strain.


Subject(s)
Humans , Male , Middle Aged , Community-Acquired Infections/etiology , Influenza A Virus, H1N1 Subtype , Influenza, Human/complications , Methicillin-Resistant Staphylococcus aureus/classification , Pneumonia, Staphylococcal/etiology , Republic of Korea , Staphylococcal Infections/etiology
11.
Yonsei Medical Journal ; : 328-336, 2012.
Article in English | WPRIM | ID: wpr-154811

ABSTRACT

PURPOSE: Spontaneous bacterial peritonitis (SBP) frequently develops in patients with liver cirrhosis; however, there is little data to suggest whether the acquisition site of infection influences the prognosis. This study compared the bacteriology, clinical characteristics and treatment outcomes of community-acquired SBP (CA-SBP) and nosocomial SBP (N-SBP). MATERIALS AND METHODS: The medical records of 130 patients with hepatitis B virus (HBV)-related liver cirrhosis, who had experienced a first episode of SBP between January 1999 and December 2008, were reviewed. RESULTS: The study population included 111 (85.4%) patients with CA-SBP and 19 (14.6%) patients with N-SBP. Baseline and microbiological characteristics as well as clinical course, including in-hospital mortality, did not differ between patients with CA-SBP and those with N-SBP (all p>0.05). The median survival time was 6.5 months, and 117 (90.0%) patients died during the follow-up period. Patients with CA-SBP and N-SBP survived for median periods of 6.6 and 6.2 months, respectively, without significant difference (p=0.569). Time to recurrence did not differ between patients with CA-SBP and N-SBP (4.7 vs. 3.6 months, p=0.925). CONCLUSION: The acquisition site of infection did not affect clinical outcomes for patients with HBV-related liver cirrhosis who had experienced their first episode of SBP. Third-generation cephalosporins may be effective in empirically treating these patients, regardless of the acquisition site of the infection.


Subject(s)
Female , Humans , Male , Middle Aged , Community-Acquired Infections/etiology , Hepatitis B virus/pathogenicity , Liver Cirrhosis/complications , Peritonitis/etiology , Retrospective Studies
12.
Rev. gaúch. enferm ; 32(2): 402-410, jun. 2011. tab
Article in Portuguese | LILACS, BDENF | ID: lil-596551

ABSTRACT

Os clientes com câncer apresentam complicações significativas de morbi-mortalidade relacionadas à infecção. Esta revisão integrativa tem como objetivo analisar a produção científica da enfermagem acerca do controle de infecções nos clientes com câncer. A busca dos 37 artigos incluídos foi por meio eletrônico em bases de dados, no período de 2002 a 2009. Os dados foram analisados na perspectiva da Metodologia de Categorização Epistemológica para a Pesquisa na Enfermagem. Os resultados indicam que a produção é internacional, mais setorizada na área da oncologia clínica, com ênfase nos clientes como sujeitos das investigações, tendência exógena da origem da infecção e prevalência de artigos de revisão de literatura. Conclui-se que a produção do conhecimento no controle de infecção é prioridade no cenário nacional, as ações devem ser baseadas numa visão sistêmica, considerando a complexidade que envolve os profissionais na prestação do cuidado de enfermagem.


Los clientes con cáncer tienen complicaciones importantes de morbilidad y mortalidad relacionadas con la infección. Esta revisión integradora es analizar la producción científica de los enfermeros sobre el control de infecciones en los clientes con el cáncer. La búsqueda de los 37 artículos se insertó a través de bases de datos electrónico, en el período 2002 a 2009. Los datos fueron analizados desde la perspectiva de la metodología epistemológica para la Investigación en Enfermería. Los resultados indican que la producción es internacional, el área más sectorizado de la oncología clínica, la tendencia fuente exógena de infección y prevalecía de la literatura revisada. Se concluye que la producción de conocimiento en el control de la infección es una prioridad en la escena nacional, las acciones deben basarse en una visión sistémica, teniendo en cuenta la complejidad que implica en el cuidado profesional de enfermería.


Customers with cancer have significant complications of morbidity and mortality related to infection. This integrative review is to analyze the scientific production of nurses about infection control in clients with cancer. The search of the 37 articles included was through electronic databases, from 2002 to 2009. Data were analyzed from the perspective of epistemological categorization methodology for Research in Nursing. The results indicate that production is international, more sectorized area of clinical oncology, with emphasis on customers as subjects of investigations, trend exogenous source of infection and prevalence of reviewed literature. It is concluded that the production of knowledge in infection control is a priority on the national scene, the actions must be based on a systemic view, considering the complexity involved in providing professional nursing care.


Subject(s)
Humans , Infection Control , Knowledge , Nursing Research/statistics & numerical data , Oncology Nursing , Bibliometrics , Brazil , Community-Acquired Infections/etiology , Community-Acquired Infections/prevention & control , Cross Infection/etiology , Cross Infection/prevention & control , Databases, Bibliographic/statistics & numerical data , Disease Susceptibility , Immunocompromised Host , Infection Control/methods , Infections/etiology , Neoplasms/complications , Neoplasms/immunology , Neoplasms/therapy , Periodicals as Topic/statistics & numerical data , United States , Global Health
13.
Medicina (B.Aires) ; 71(2): 127-134, mar.-abr. 2011. ilus, graf, tab
Article in Spanish | LILACS | ID: lil-633831

ABSTRACT

El objetivo del trabajo es comunicar los hallazgos epidemiológicos, clínicos y de diagnóstico de la neumonía y hemorragia pulmonar por leptospirosis, en el período enero 2007 a octubre 2009. Un 64% (20/31) de pacientes con diagnóstico de leptospirosis tuvieron neumonía. Quince de ellos (75%) presentaron neumonía grave, de los cuales siete (35%) desarrollaron hemorragia pulmonar. En diez enfermos (32%) el motivo de consulta e inicio del cuadro clínico fue una gastroenteritis secretoria con fiebre y dolor abdominal. La ictericia sólo se manifestó en once pacientes (35%). La técnica de reacción en cadena de la polimerasa (PCR) fue útil para el diagnóstico en muestra obtenida post mortem. De un hemocultivo se aisló una cepa clasificada dentro del serogrupo canicola. Se clasificaron las neumonías en tres tipos: neumonías de curso no grave con escasa repercusión general; neumonías graves asociadas a formas clínicas sistémicas con ictericia, insuficiencia renal, trombocitopenia y hemorragia pulmonar; también de curso grave, no asociada a ictericia, insuficiencia renal o trombocitopenia grave. El tratamiento antibiótico iniciado en los primeros días de enfermedad (promedio 3.2 días) no tuvo influencia en la evolución de las neumonías graves. Se plantea además considerar tres formas clínicas de leptospirosis: anictérica, ictérica (con sus variantes evolutivas) y hemorragia pulmonar.


The aim of this paper is to report the epidemiological, clinical and diagnosis findings of pneumonia and pulmonary hemorrhage observed in patients with leptospirosis in the period January 2007 to October 2009. A 64% (20/31) of patients diagnosed with leptospirosis presented pneumonia. Fifteen of them (75%) had severe pneumonia, of which seven (35%) were pulmonary hemorrhage. In ten patients (32%) reason for consultation and clinical early stage was a secretory gastroenteritis with fever and abdominal pain. Jaundice was only expressed in eleven patients (35%). The technique of chain reaction (PCR) was useful for diagnosis in samples obtained post mortem. A strain classified in serogroup canicola was isolated from blood culture. Pneumonia was classified into three types: non-severe pneumonia course with little overall impact; severe pneumonia associated with systemic clinical forms with jaundice, renal failure, thrombocytopenia, and pulmonary hemorrhage, and of serious course, not associated with jaundice, kidney failure or thrombocytopenia. Antibiotic treatment started in the early stages of disease (average 3.2 days) had no influence on the development of severe pneumonia. It is puggested to consider three clinical forms of leptospirosis: anicteric, icteric (with its evolutionary variants) and pulmonary hemorrhage.


Subject(s)
Adolescent , Adult , Aged , Aged, 80 and over , Child , Female , Humans , Male , Middle Aged , Young Adult , Hemorrhage/etiology , Leptospirosis/complications , Lung Diseases/etiology , Pneumonia, Bacterial/etiology , Acute Kidney Injury/etiology , Argentina/epidemiology , Community-Acquired Infections/epidemiology , Community-Acquired Infections/etiology , Leptospirosis/epidemiology , Polymerase Chain Reaction , Pneumonia, Bacterial/epidemiology , Severity of Illness Index
14.
Indian J Ophthalmol ; 2010 Nov; 58(6): 497-507
Article in English | IMSEAR | ID: sea-136114

ABSTRACT

Aims: To identify the etiology, incidence and prevalence of ocular bacterial infections, and to assess the in vitro susceptibility of these ocular bacterial isolates to commonly used antibiotics. Materials and Methods: Retrospective analysis of consecutive samples submitted for microbiological evaluation from patients who were clinically diagnosed with ocular infections and were treated at a tertiary eye care referral center in South India between January 2002 and December 2007. Results: A total of 4417 ocular samples was submitted for microbiological evaluation, of which 2599 (58.8%) had bacterial growth, 456 (10.3%) had fungal growth, 15 (0.34%) had acanthamoebic growth, 14 (0.32%) had mixed microbial growth and the remaining 1333 (30.2%) had negative growth. The rate of culture-positivity was found to be 88% (P < 0.001) in eyelids’ infection, 70% in conjunctival, 69% in lacrimal apparatus, 67.4% in corneal, 51.6% in intraocular tissues, 42.9% in orbital and 39.2% in scleral infections. The most common bacterial species isolated were Staphylococcus aureus (26.69%) followed by Streptococcus pneumoniae (22.14%). Sta. aureus was more prevalent more in eyelid infections (51.22%; P = 0.001) coagulase-negative staphylococci in endophthalmitis (53.1%; P = 0.001), Str. pneumoniae in lacrimal apparatus and corneal infections (64.19%; P = 0.001), Corynebacterium species in blepharitis and conjunctivitis (71%; P = 0.001), Pseudomonas aeruginosa in keratitis and dacryocystitis (66.5%; P = 0.001), Haemophilus species in dacryocystitis and conjunctivitis (66.7%; P = 0.001), Moraxella lacunata in blepharitis (54.17%; P = 0.001) and Moraxella catarrhalis in dacryocystitis (63.83%; P = 0.001). The largest number of gram-positive isolates was susceptible to moxifloxacin (98.7%) and vancomycin (97.9%), and gram-negative isolates to amikacin (93.5%) and gatifloxacin (92.7%). Conclusions: Gram-positive cocci were the most frequent bacteria isolated from ocular infections and were sensitive to moxifloxacin and vancomycin, while gram-negative isolates were more sensitive to amikacin and gatifloxacin.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Bacteria/drug effects , Community-Acquired Infections/drug therapy , Community-Acquired Infections/etiology , Community-Acquired Infections/microbiology , Eye Infections, Bacterial/drug therapy , Eye Infections, Bacterial/etiology , Eye Infections, Bacterial/microbiology , Humans , India , Microbial Sensitivity Tests
15.
Rev. panam. salud pública ; 26(2): 101-111, Aug. 2009. tab
Article in Spanish | LILACS | ID: lil-528127

ABSTRACT

OBJETIVOS: Determinar los costos médicos directos relacionados con la atención sanitaria de los casos de enfermedades neumocócicas invasoras (ENI) y neumonías adquiridas en la comunidad confirmadas mediante radiología (NAC-Rx) en niños chilenos. MÉTODO: Estudio de seguimiento prospectivo de las prestaciones de salud entregadas a 594 niños de 0 a 35 meses con ENI y 1489 niños de 1 a 35 meses con NAC-Rx, diagnosticados y tratados en establecimientos de la red pública de salud de la Región Metropolitana de Chile. Las prestaciones se valoraron según las tarifas del Fondo Nacional de Salud (FONASA) y los precios de dos clínicas privadas. Se estimó la incidencia nacional anual de ENI y NAC-Rx para calcular la carga económica total nacional de la población afiliada al seguro de salud estatal. RESULTADOS: Los costos promedio de los casos que requirieron hospitalización fueron US$ 1056,20 para las ENI y US$ 594,80 para las NAC-Rx, mientras que para los casos tratados en forma ambulatoria fueron US$ 77,70 y US$ 65,20, respectivamente. Los precios por los mismos servicios de internación fueron US$ 4484,10 y US$ 2962,70 en una de las clínicas privadas y US$ 9967,50 y US$ 6578,40 en la otra. El costo anual nacional estimado de la atención de los niños menores de 5 años según las tarifas de FONASA fue de US$ 789045 para las ENI y US$ 13823289 para las NAC-Rx. CONCLUSIONES: La alta demanda asistencial y económica por NAC-Rx en niños de 0 a 3 años es una razón de salud pública tremendamente poderosa que apoya el uso sistemático de la vacunación antineumocócica en niños chilenos.


OBJECTIVES: To determine the direct medical costs of health care services for cases of invasive pneumococcal disease (IPD) and pneumonia acquired in the community and confirmed by radiology (NAC-Rx) among Chilean children. METHODS: A prospective follow-up study of the health services delivered to 594 children 0-35 months of age with IPD and 1 489 children 1-35 months with NAC-Rx, diagnosed and treated by organizations within public health network of the Región Metropolitana de Chile. The value of the health services was established according to rates supplied by the Fondo Nacional de Salud (FONASA, the National Health Fund) and prices charged by two private clinics. The national IPD and NAC-Rx rates were estimated to calculate the total national economic burden for the population covered by state health insurance. RESULTS: The mean cost of cases requiring hospitalization was US$ 1056.20 for IPD and US$ 594.80 for NAC-Rx, while that of cases treated by out-patient services was US$ 77.70 and US$ 65.20, respectively. The cost of the same services for in-patient care at the private clinics was US$ 4484.10 and US$ 2962.70 at one clinic and US$ 9967.50 and US$ 6578.40 at the other. The estimated national annual cost of services for children under 5 years of age, according to FONASA rates, was US$ 789045 for IPD and US$ 13823289 for NAC-Rx. CONCLUSION: The high demand for services and financial resources for NAC-Rx in children 0-3 years of age is a tremendously powerful public health reason to support the routine use of pneumococcal vaccination in Chilean children.


Subject(s)
Child, Preschool , Female , Humans , Infant , Male , Health Care Costs , Pneumonia, Pneumococcal/economics , Pneumonia, Pneumococcal/therapy , Chile , Community-Acquired Infections/etiology , Community-Acquired Infections/therapy , Follow-Up Studies , Pneumonia, Pneumococcal , Prospective Studies
16.
Brasília méd ; 46(3)2009.
Article in Portuguese | LILACS | ID: lil-531640

ABSTRACT

A pneumonia adquirida na comunidade permanece como doença muito prevalente e de alta mortalidade em todo o mundo. Apesar dos avanços tecnológicos, o diagnóstico etiológico da doença, até em grandes centros, só é possível em um percentual não significativo. Neste artigo de revisão, faz-se uma análise compacta dos vários agentes causais desse tipo de pneumonia, com ilações sobre aspectos epidemiológicos e de gravidade.


Community-acquired pneumonia in the community remains a very prevailing disease, with high mortality rate all over the world. Despite all the technological advancements, the etiological diagnosis of this disease even in major cities is only possible in a non-significant percentage. In this reviewing paper, a compact analysis on several etiological agents that causes this sort of pneumonia is reported, taking some illations on the epidemiologic aspects and its severity.


Subject(s)
Humans , Community-Acquired Infections/epidemiology , Community-Acquired Infections/etiology , Pneumonia/epidemiology , Pneumonia/etiology
17.
Bol. venez. infectol ; 18(1): 5-9, ene.-jun. 2007. tab, graf
Article in Spanish | LILACS | ID: lil-721152

ABSTRACT

Demostrar que el cefprozil es eficaz y seguro en neumonías adquiridas en la comunidad en edad pediátrica en aquellos casos donde no existan evidencias de complicaciones. Se seleccionaron 30 niños de ambos sexos mayores de 6 meses de edad que cumplieron con los criterios de inclusión, con posibilidades de cumplir el tratamiento en forma ambulatoria, suministrándole el cefprozil a dosis de 50 mg/kg/peso/día por vía oral con controles diarios por un lapso de 7 a 10 días, realizándosele evaluación clínica y examen físico detallados, así como pruebas de laboratorio y cultivos. Predominó el sexo masculino (66,6 por ciento). La mayor incidencia por grupo etario fue entre 6 meses y 5 años de edad, con un promedio de 5 años. La fiebre y la tos estuvieron presentes en 15 de los casos (50 por ciento), el hemograma mostró leucocitosis con neutrofilia y positividad de la VSG y PCR en el 50 por ciento de los casos. El hemocultivo fue positivo para Streptococcus pneumoniae (3 = 10 por ciento) y Moraxella catarralis (1 = 3,33 por ciento), siendo negativos en un 86.66 por ciento. El hallazgo radiológico reveló infiltrado intersticial difuso bilateral (22 = 73,33 por ciento) y focos de consolidación (8 = 26,66 por ciento). El fármaco mostró seguridad y eficacia en el 93,33 por ciento de los casos y no se evidenció efectos colaterales. La terapia con cefprozil en NAC en edad pediátrica demostró eficacia terapéutica sin efectos adversos y con beneficios clínicos y económicos tanto para el paciente como para los padres. Asimismo, la terapia con cefprozil en NAC representa una alternativa eficaz en tratamientos ambulatorios por vía oral y disminuye la masificación en hospitalizaciones innecesarias.


Subject(s)
Humans , Male , Female , Child , Cephalosporins/administration & dosage , Community-Acquired Infections/etiology , Pneumonia/diagnosis , Pneumonia/therapy , beta-Lactams/administration & dosage , Cephalosporins/pharmacology , Infectious Disease Medicine , Pediatrics , beta-Lactams/pharmacology
19.
Rev. méd. Chile ; 135(4): 517-528, abr. 2007. ilus, tab
Article in Spanish | LILACS | ID: lil-456665

ABSTRACT

Distinguishing pneumonia from other causes of respiratory illnesses, such as bronchitis, influenza and upper respiratory tract infections, has important therapeutic and prognostic implications. This decision is usually made by clinical assessment alone or by performing a chest x-ray. The reference standard for diagnosing pneumonia is chest radiography, but many physicians rely on history and physical examination to diagnose or exclude this disease. A review of published studies of patients suspected of having pneumonia reveals that there are no individual clinical findings, or combination of findings, that can predict with certainty the diagnosis of pneumonia. Prediction rules have been recommended to guide the order of diagnostic tests, to maximize their clinical utility. Thus, some studies have shown that the absence of any vital sign abnormalities or any abnormalities on chest auscultation substantially reduces the likelihood of pneumonia to a point where further diagnostic evaluation may be unnecessary. This article reviews the literature on the appropriate use of the history and physical examination in diagnose community-acquired pneumonia.


Subject(s)
Adult , Humans , Medical History Taking , Physical Examination , Pneumonia/diagnosis , Auscultation , Bronchitis/diagnosis , Community-Acquired Infections/diagnosis , Community-Acquired Infections/etiology , Diagnosis, Differential , Influenza, Human/diagnosis , Likelihood Functions , Pneumonia/etiology , Predictive Value of Tests
20.
J. bras. med ; 91(5/6): 3-36, nov.-dez. 2006. tab
Article in Portuguese | LILACS | ID: lil-603846

ABSTRACT

A pneumonia é uma infecção que envolve os alvéolos e os bronquíolos, podendo ser causada por bactéria, vírus ou parasitas. Pneumonia adquirida na comunidade (PAC) é a que acomete o paciente fora do ambiente hospitalar ou em até 48 horas após admissão. A PAC é a segunda causa de internação no Brasil, estando a mesma associada a morbidade e mortalidade significativas e custo elevado.


Subject(s)
Humans , Community-Acquired Infections/epidemiology , Community-Acquired Infections/etiology , Community-Acquired Infections/transmission , Pneumonia , Risk Factors , Streptococcus pneumoniae
SELECTION OF CITATIONS
SEARCH DETAIL